Health Care: Drugs

NewLink Genetics Corp (NLNK: NASDAQ)

$37.14 n/a | n/a%
11/25/15 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 37.14
52 Week High 58.73
52 Week Low 31.70
Avg. Daily Vol. (Mil) 0.54
Beta (3 year) 0.76
Share Related Items
Mkt Cap (Mil) 1,069.09
Shares Out (Mil) 28.79
Float (Mil) 20.68
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 18.90
Current Ratio 19.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 10.70
Price/Sales 4.65
Price/Book 5.15
Price/Cash Flow 9.80
Per Share Data
Earnings 3.48
Sales 7.99
Book Value 7.21
Cash Flow 3.80
Business Summary
NewLink Genetics Corp is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing immunotherapeutic products to improve treatment options for patients with cancer.
General Information
2503 South Loop Drive
Suite 5100
Ames, IA 50010
Industry : Drugs
Sector: Health Care
Employees: 130
CEO: Mr. Charles J. Link, Jr
Short Interest
Current Month (Mil) 5.18
Previous Month (Mil) 4.55
Short Interest Ratio (Days) 8.30
Management Effectiveness
Return on Equity 52.10
Return on Assets 47.60
Return on Investments 52.00
Gross Margin n.a.
EBIT Margin 56.10
Profit Margin 47.00

Portfolios with NLNK

Latest NLNK Headlines from TheStreet

More Financial News for NLNK

Press Releases for NLNK

See All Press Releases

Partner Headlines for NLNK

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter